CNR Institutional Research Information System

PANI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.018
NA - Nord America 1.260
SA - Sud America 425
EU - Europa 362
AF - Africa 39
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.108
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.226
SG - Singapore 856
CN - Cina 492
BR - Brasile 347
VN - Vietnam 214
HK - Hong Kong 203
FR - Francia 115
IT - Italia 93
KR - Corea 83
NL - Olanda 52
AR - Argentina 34
JP - Giappone 33
IN - India 24
ID - Indonesia 22
GB - Regno Unito 18
FI - Finlandia 17
BD - Bangladesh 16
MX - Messico 15
PE - Perù 13
ZA - Sudafrica 12
IL - Israele 11
IQ - Iraq 11
RU - Federazione Russa 11
SA - Arabia Saudita 11
CA - Canada 8
DE - Germania 8
EC - Ecuador 8
PY - Paraguay 8
TR - Turchia 7
AT - Austria 6
CO - Colombia 6
KE - Kenya 6
MA - Marocco 6
PK - Pakistan 6
PL - Polonia 6
ES - Italia 5
GR - Grecia 5
KZ - Kazakistan 5
SE - Svezia 5
AZ - Azerbaigian 4
CH - Svizzera 4
CL - Cile 4
JO - Giordania 4
UA - Ucraina 4
AU - Australia 3
CR - Costa Rica 3
AL - Albania 2
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
GT - Guatemala 2
LT - Lituania 2
MY - Malesia 2
NA - Namibia 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
RE - Reunion 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.108
Salva come PNG Salva come JPEG
Città #
Santa Clara 749
Singapore 497
Hefei 204
Hong Kong 201
Lauterbourg 99
San Jose 84
Seoul 83
Beijing 75
Ho Chi Minh City 65
Hanoi 63
Ashburn 56
Los Angeles 45
Cagliari 34
Buffalo 29
New York 22
São Paulo 22
Tokyo 20
Helsinki 17
Rome 15
Rio de Janeiro 14
Dallas 12
Minamishinagawa 12
Belo Horizonte 10
Lima 10
Da Nang 9
Phoenix 8
Curitiba 7
Haiphong 7
Campinas 6
Fortaleza 6
Guangzhou 6
Johannesburg 6
Milan 6
Orem 6
Asunción 5
Biên Hòa 5
Brasília 5
Can Tho 5
Dhaka 5
Goiânia 5
Jeddah 5
Nairobi 5
Poplar 5
Sassari 5
Shenzhen 5
Thái Bình 5
Thái Nguyên 5
Baku 4
Chennai 4
Durban 4
Houston 4
Istanbul 4
Joinville 4
Manaus 4
Nam Định 4
Praia Grande 4
Riyadh 4
Salvador 4
Santo André 4
Shanghai 4
Stockholm 4
São Bernardo do Campo 4
Tây Ninh 4
Warsaw 4
Almaty 3
Baghdad 3
Buenos Aires 3
Bắc Ninh 3
Cuiabá 3
Frankfurt am Main 3
Gentilino 3
Guayaquil 3
Jakarta 3
João Pessoa 3
Las Vegas 3
Maceió 3
Maringá 3
Moscow 3
Mumbai 3
Philadelphia 3
Phủ Lý 3
Quận Bình Thạnh 3
Vienna 3
Votorantim 3
Addis Ababa 2
Agadir 2
Alimos 2
Amman 2
Athens 2
Bari 2
Bengaluru 2
Birmingham 2
Boston 2
Botucatu 2
Brescia 2
Bridgetown 2
Brooklyn 2
Bình Dương Province 2
Bến Lức 2
Carapicuíba 2
Totale 2.730
Salva come PNG Salva come JPEG
Nome #
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors 93
Validated Method to Determine Quetiapine and Norquetiapine in Microsomal Matrix by LC MS-MS: Implication in Quetiapine Metabolism 78
P-450 and Antipsychotics 71
second life in Schizophrenia 66
Farmacologia transnosografica: l?esempio degli antipsicotici atipici 65
Psicofarmaci: trame storiche, prospettive farmacologiche, implicazioni cliniche 64
PK-PD of new antipsychotics and their clinical value. 60
Meccanismi di plasticità neuronale dopamino-correlati 56
PK-PD of new antipsychotics and their clinical value. 56
1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. 56
Practical issues with amisulpride in the management of patients with schizophrenia 54
Molecular characterization of new polymorphisms at the b2, a1, g2 GABAA receptor subunit genes associated to a rat non-preferring ethanol phenotype 54
New pharmacological perspectives in the treatment of schizophrenia 51
Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent. 50
Composti farmaceutici Diazabicyclic compounds as opioid receptor agonists 50
Psicofarmacologia Essenziale, Basi Neuroscientifiche e Applicazioni Pratiche 49
Meccanismi molecolari della plasticità neuronale: implicazioni terapeutiche 48
Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study 48
Characterization of wild-type (R100R) and mutated (Q100Q) GABAA a6 subunit in Sardinian alcohol non-preferring rats (sNP). 48
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release 47
  Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry 47
Building a virtual archive using brain architecture and Web 3D to deliver 46
Cocaine Abuse and the Therapy of related Psychosis 45
second life in Schizophrenia 43
Synthesis and in vitro evaluation of trifluoroethylamine analogues of enkephalines 43
Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors 43
Antipsychotic new pharmaceutical formulations 43
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2',4'-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazo le-3-carboxamide 41
An history of Chocolate and its effect on the brain 41
Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats. 41
Composition of spores of non pathogenic bacteria 40
Cytochrome P450 gene variations analysis using MALDI-TOF technology 40
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. 40
Neurodoping o psicodoping? Gli Stimolanti. 39
Management of Comorbidity in Bipolar Disorder in: Bipolar Disorder: Clinical and Neurobiological Foundations 39
Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol 39
Effects of acute and chronic valproate treatments on p-CREB levels in the rat amygdala and nucleus accumbens 39
Microemulsioni 38
Continuous paliperidone infusion versus repeated risperidone injections on cognition, prolactinemia and body weight in rats 38
The atypical antipsychotic Ziprasidone reduces stress-induced increases in dopamine release in the mouse prefrontal cortex 38
Antipsychotic efficacy with new pharmaceutical formulations 37
50 years of treatment in Schizophrenia 37
3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]hep 36
PLGA NANOPARTICLES LOADED WITH A NEW CLOZAPINE-LIKE ANTIPSYCHOTIC AGENT 36
SYNTHESIS AND PRELIMINARY BIOLOGICAL EVALUATION OF NEW PARTIALLY FLUORINATED THIOL DUAL INHIBITORS OF NEUTRAL ENDOPEPTIDASE 24.11 AND ANGIOTENSIN CONVERTING ENZYME 35
Le Imprese e i Centri di Ricerca della sede centrale di Polaris: Neuroscienze 35
Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays 35
New perspectives on efficacy in the treatment of schizophrenia 34
Consensus on the use of substituted benzamides in psychiatric patients. 34
Positioning Paliperidone in Asian Markets 34
Pharmacokinetics and Pharmacodynamics of New Antipsychotics 34
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain. 34
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. 34
Paliperidone-ER a new antpsychotic 33
Haloperidol, but not clozapine, produces dramatic catalepsy in Delta9-THC-treated rats: possible clinical implications 33
Optimization of PK-PD for better outcomes. 33
Gli antipsicotici atipici nella terapia dei disturbi cognitivi dell?anziano 33
Multiplex genotyping of CYP2D6 polymorphisms by MALDI-TOF mass spectrometry. 32
Co-release of noradrenaline and dopamine from neuroadrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. 32
Risperidone RP pharmacology and clinical use 32
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors. 32
Effect of duloxetine in conditioned and unconditioned behavioural models of anxiety 31
Il profilo farmacologico degli antipsicotici atipici: similitudini e differenze 31
Paliperidone-ER a new antpsychotic from preclinical to clinical data 31
Effect of 1-butanol on the microstructure of lecithin/water/tripalmitin system. 31
Evolutionary Psychopharmacology, Mental Disorders, and Ethical Behavior 31
Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia 31
Paliperidone-ER a new antipsychotic from preclinical to clinical data 30
second life in Schizophrenia 30
Paliperidone-ER a new antipsychotic from preclinical to clinical data 30
New formulation of drugs in Psychopharmacology. 29
Risperidone RP pharmacology and clinical use 29
Emozioni e Malattia. Dall'evoluzione del pensiero biologico al tramonto del pensiero psicosomatico 29
Uso di agonisti GABAb per la terapia di mantenimento dell'astinenza da nicotina in soggetti nicotino dipendenti 29
Paliperidone-ER a new antpsychotic 29
Pharmakinetics and Pharmacodynamics of New Antipsychotics 29
Paliperidone-ER a new antpsychotic from preclinical to clinical data 28
TRICYCLIC PYRAZOLES. SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL 4,5-DIHYDRO-1H-6-OXA-CYCLOHEPTA[1,2-c]PYRAZOLE-BASED ANALOGUES OF CANNABINOID ANTAGONIST NESS 0327 28
Building a virtual archive using brain architecture and Web 3D to deliver 28
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor. 28
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide. 28
Second Life in Schizophrenia 27
Cosa gli studi sull?abuso di sostanze insegnano alla Psichiatria? 27
Paliperidone-ER a new antipsychotic from preclinical to clinical data 27
Microstructural characterization of D9-Tetrahydrocannabinol non-ionic microemulsions with antinociceptive activity 26
Mechanism of action of new Antipsychotic drugs 26
second life in Schizophrenia 26
SELECTIVE VOLUME REDUCTION OF ANTERIOR CINGULATE CORTEX IN YOUNG ADULT RATS AFTER NEONATAL EXCITOTOXIC LESION OF VENTRAL HIPPOCAMPUS 26
Rimodellare gli obiettivi del trattamento antipsicotico 25
Different striatal c-fos expression following co-administration of Delta-9-Tetrahydrocannabinol with haloperidol or clozapine. 25
Second Life in Schizophrenia 25
EVALUATION OF SYNTHETIC TUBULYSIN U INDUCED CYTOTOXICITY IN HL60, C6, PC12 AND ECV304 CELL LINES 25
Razionale farmacologico dell?utilizzo di un atipico long-acting nel trattamento dei pazienti a bassa adesione 25
second life in Schizophrenia 24
Farmacogenetica degli Antiipsicotici 24
Paliperidone-ER, PK-PD profile and preclinical data. 24
Risperidone RP pharmacology and clinical use 24
Second Life in Schizophrenia 24
Risperidone RP pharmacology and clinical use 24
La sicurezza nell?uso degli psicofarmaci e la Drug-Drug interaction 23
Totale 3.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.708
article - articoli 3.713
book - libri 226
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 311
Totale 15.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202410 0 0 0 0 0 0 0 0 6 0 2 2
2024/20251.826 6 7 120 105 649 114 64 20 29 56 357 299
2025/20262.287 127 194 289 387 433 133 310 140 122 112 39 1
Totale 4.123